Marijn Dekkers, chief executive officer of Bayer AG, speaks during a news conference to announce the drugmaker's earnings at the company's headquarters in Leverkusen, Germany, on Friday, Feb. 28, 2014. Bayer raised its forecast for peak sales of new drugs such as the blood thinner Xarelto even as fourth-quarter results and the revenue outlook for this year missed analyst estimates. Photographer: Jasper Juinen/Bloomberg via Getty Images
Getty Images

Bloomberg Bloomberg